AbEnalp 10mg Tablet

Trade Name: AbEnalp 10

Manufacturer: Abbott

Presentation: Tablets

Strength: Enalapril Maleate 10mg

AbEnalp 10mg Tablet is a prescription medicine that contains enalapril maleate, a medicine commonly used to treat high blood pressure (hypertension) and heart failure. It belongs to a class of medicines called angiotensin-converting enzyme (ACE) inhibitors, which work by relaxing blood vessels and improving blood flow, thereby reducing the workload on the heart.

Key Uses

  1. Hypertension Management: Helps lower high blood pressure, thereby reducing the risk of heart attack, stroke, and kidney damage.
  2. Heart Failure: Improves symptoms by increasing the heart’s ability to pump blood efficiently.
  3. Kidney Protection: Beneficial for patients with diabetes or kidney disease by protecting kidney functioning.

Dosage and Administration

  • The usual dosage is determined by the healthcare provider based on the patient’s condition and response to treatment.
  • It is usually taken once daily, with or without food.

AbEnalp 10mg Tablet Common Side Effects

  • Dizziness or lightheadedness (especially when starting treatment)
  • Dry cough
  • Fatigue
  • Headache
  • Increased potassium levels

Precautions:

  • Regular monitoring of blood pressure, kidney function, and potassium levels is recommended.
  • Not recommended during pregnancy or breastfeeding.
  • Use with caution in patients with renal impairment or a history of angioedema.

Storage

  • Store in a cool, dry place away from direct sunlight and moisture.
  • Keep out of reach of children.

AbEnalp 10mg Tablet is an effective treatment option for managing high blood pressure and cardiovascular conditions under the guidance of a healthcare professional.

Check this Anti-inflammatory product Abrozu Gold Capsuleor you may explore more Anti-inflammatory products by clicking here

We are an exporter from India and work in many countries, such as the UAE, Oman, Qatar, Myanmar, Saudi Arabia, the Netherlands, Albania, Saint Lucia, Jordan, Romania, and South Africa.